To hear about similar clinical trials, please enter your email below
Trial Title:
Lung Cancer ID (Identity) Study
NCT ID:
NCT06076005
Condition:
Lung Cancer Stage IV
Conditions: Official terms:
Lung Neoplasms
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
Advanced lung cancer patients' group
Description:
Evaluation of the demographic, clinical, histological and molecular characteristics of
advanced lung cancer at the time of Diagnosis
Summary:
The distribution of demographic, clinical, radiological, pathological and molecular
characteristics of lung cancer at the time of diagnosis, as well as preferential
association between elements of those domains, have not been specifically studied in
Italy. The aim of the present project is to assess, in a systematic fashion, the
demographic, clinical, radiological, pathological and molecular characteristics of
advanced lung cancer at the time of diagnosis in a large Italian cohort of consecutive
patients referred to two tertiary referral centers.
Criteria for eligibility:
Study pop:
Consecutive, treatment-naïve, patients with clinical and radiological suspicion of
advanced lung cancer referred for the initial diagnosis/staging/molecular profiling.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Age >18 years
- Suspicion of lung cancer based on imaging (CT and/or PET/CT)
- Indication to a biopsy for diagnosis, staging and/or molecular profiling
Exclusion Criteria:
- Inability or unwillingness to provide a written informed consent
- ECOG performance status (>3) which makes a tissue diagnosis unfeasible
- ASA 4 status
- TNM Stage I-III
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Locations:
Facility:
Name:
Interventional Pulmonology Division - Fondazione Policlinico Universitario A. Gemelli IRCCS
Address:
City:
Roma
Country:
Italy
Status:
Recruiting
Contact:
Last name:
Marta Viscuso, MD
Email:
marta.viscuso@guest.policlinicogemelli.it
Facility:
Name:
Istituto Nazionale Tumori Regina Elena
Address:
City:
Roma
Country:
Italy
Status:
Not yet recruiting
Contact:
Last name:
Federico Cappuzzo, MD
Facility:
Name:
Medical Oncology Division - Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Address:
City:
Roma
Country:
Italy
Status:
Not yet recruiting
Contact:
Last name:
Emilio Bria
Start date:
November 1, 2023
Completion date:
October 31, 2025
Lead sponsor:
Agency:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Agency class:
Other
Source:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06076005
